Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 8,185 | 5,801 | 10,331 | 10,738 | 3,236 |
| Gross Profit | 8,185 | 5,801 | 10,331 | 10,738 | 3,236 |
| Operating Expenses | 62,984 | 26,266 | 53,166 | 62,784 | 14,328 |
| Operating Income | -54,799 | -21,465 | -42,834 | -52,045 | -11,092 |
| Interest Expense | 9 | 2 | 297 | 162 | 39 |
| Other Income | 347 | 889 | -2,190 | 144 | 43 |
| Pre-tax Income | -54,462 | -20,579 | -45,321 | -52,064 | -11,087 |
| Income Tax | -5,417 | -59 | -6,150 | -5,638 | N/A |
| Net Income Continuous | -49,045 | -20,520 | -39,171 | -46,425 | -11,087 |
| Net Income | $-49,045 | $-20,520 | $-39,171 | $-46,425 | $-11,087 |
| EPS Basic Total Ops | -1.91 | -1.60 | -15.16 | -118.91 | -49.85 |
| EPS Basic Continuous Ops | -1.91 | -1.56 | -13.98 | -107.50 | -48.17 |
| EPS Diluted Total Ops | -1.91 | -1.60 | -15.16 | -118.91 | -49.85 |
| EPS Diluted Continuous Ops | -1.91 | -1.56 | -13.98 | -107.50 | -48.17 |
| EPS Diluted Before Non-Recurring Items | -1.91 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-54,370 | $-20,078 | $-17,591 | $-15,987 | $-10,956 |